Clinical Trials in Peru, United States
Locations / Peru, United States
Delta Trials hosts 547 clinical trials conducted in Peru, United States, making it a notable site of clinical research activity. These trials covering 1,593 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 33 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Peru.
547
Total Trials
1593
Conditions
33
Terminated since 2020
Browse by condition (1593 total)
- Breast cancer 43 trialsAll Breast cancer trials
- Lung cancer 20 trialsAll Lung cancer trials
- Lymphoma 19 trialsAll Lymphoma trials
- Stage iv lung cancer ajcc v8 16 trialsAll Stage iv lung cancer ajcc v8 trials
- All Unspecified adult solid tumor, protocol specific trials
- Colorectal cancer 12 trialsAll Colorectal cancer trials
- Recurrent lung non-small cell carcinoma 12 trialsAll Recurrent lung non-small cell carcinoma trials
- Leukemia 12 trialsAll Leukemia trials
- Recurrent ovarian carcinoma 12 trialsAll Recurrent ovarian carcinoma trials
- Recurrent breast carcinoma 12 trialsAll Recurrent breast carcinoma trials
- Invasive breast carcinoma 11 trialsAll Invasive breast carcinoma trials
- Stage iv breast cancer ajcc v6 and v7 10 trialsAll Stage iv breast cancer ajcc v6 and v7 trials
- Recurrent squamous cell lung carcinoma 10 trialsAll Recurrent squamous cell lung carcinoma trials
- Recurrent fallopian tube carcinoma 10 trialsAll Recurrent fallopian tube carcinoma trials
- All Recurrent primary peritoneal carcinoma trials
- All Anatomic stage iii breast cancer ajcc v8 trials
- All Anatomic stage ii breast cancer ajcc v8 trials
- Stage iiib lung cancer ajcc v8 9 trialsAll Stage iiib lung cancer ajcc v8 trials
- Stage ivb prostate cancer ajcc v8 9 trialsAll Stage ivb prostate cancer ajcc v8 trials
- All Stage iv squamous cell lung carcinoma ajcc v7 trials